Owing to overexpression of the CD44 HA receptor and the receptor of hyaluronan (hyaluronic acid, HA)-mediated motility (RHAMM) on the tumor cell surface, tumor cells with high metastatic activity often exhibit increased binding and uptake of HA 190. The gene discussed is CD44; the disease is neoplasm.